Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.45 −2.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.07 +10.9% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.45 −2.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.07 +10.9% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Financings

California Nanotechnologies arranges $750,000 placement

CNO · Price

Executive Summary

  • California Nanotechnologies Corp. announced a non-brokered private placement of up to 2.5 million units at $0.30 per unit, targeting gross proceeds of up to $750,000.
  • The offering includes an overallotment option for an additional 1 million units, which would generate an extra $300,000 in gross proceeds.
  • Proceeds are intended for general working capital and corporate purposes, subject to regulatory approvals including TSX Venture Exchange consent.

Key Details

  • Offering Structure: Non-brokered private placement of units.
  • Price: $0.30 USD per unit.
  • Base Offering Size: Up to 2.5 million units.
  • Gross Proceeds (Base): Up to $750,000.
  • Overallotment Option: Allows for the sale of an additional 1 million units.
  • Additional Gross Proceeds (Overallotment): Up to $300,000.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant is exercisable for one additional common share at an exercise price of $0.30 USD.
  • Warrant Expiry: 18 months from the closing of the offering.
  • Use of Proceeds: General working capital and corporate purposes.
  • Insider Participation: Expected to be up to 20% of the offering.
  • Regulatory Status: Subject to receipt of all necessary regulatory approvals, including TSX Venture Exchange approval.
  • Related Party Transaction: Insider participation will be treated as a related party transaction under TSX-V and MI 61-101 policies. The company anticipates relying on exemptions from minority shareholder approval and formal valuation requirements.
  • Fees: Finders' fees may be payable in connection with the offering.
Read the original news release →

More from California Nanotechnologies Corp